These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2523648)

  • 21. Isradipine in essential hypertension: the Belgian General Practitioners' Study.
    De Keyser P; Bouvé J; Clement D; Degraef R; Meurant JP; Rorive G; Van Thillo J
    Am J Med; 1989 Apr; 86(4A):103-9. PubMed ID: 2565687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats.
    Lacolley P; Ghodsi N; Glazer E; Challande P; Brissac AM; Safar ME; Laurent S
    Br J Pharmacol; 1995 Aug; 115(7):1235-44. PubMed ID: 7582551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL; Jespersen LT; Mulvany MJ
    J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
    Simonsen K; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of isradipine in hypertension following coronary artery bypass surgery.
    Underwood SM; Feneck RO; Davies SW; Walesby RK; Lunnon MW
    Am J Med; 1989 Apr; 86(4A):81-7. PubMed ID: 2523661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term isradipine treatment on the hypertension-dependent changes in coronary arteries in spontaneously hypertensive rats.
    Ferrante F; Amenta F
    Drugs Exp Clin Res; 1991; 17(7):363-70. PubMed ID: 1838976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of isradipine on blood pressure and renal function.
    Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
    Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
    Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review.
    Dahlöf B
    Cor Vasa; 1990; 32(2 Suppl 1):23-34. PubMed ID: 2143458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of TTC-909 on cerebral infarction following permanent occlusion of the middle cerebral artery in stroke prone spontaneously hypertensive rats.
    Karasawa Y; Komiyama H; Yoshida S; Hino N; Katsuura Y; Nakaike S; Araki H
    J Pharmacol Sci; 2003 Apr; 91(4):305-12. PubMed ID: 12719659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond lowering of blood pressure. . .isradipine. Satellite symposium of the thirteenth scientific meeting of the International Society of Hypertension.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):83S-209S. PubMed ID: 1827025
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists.
    Sauter A; Rudin M; Wiederhold KH
    Neurochem Pathol; 1988; 9():211-36. PubMed ID: 3073331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of isradipine in essential hypertension.
    Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
    Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.